FDA wants more data on Acura's painkiller; India considering state-funded biotech effort;

@FierceBiotech: RT @NickPaulTaylor: EuroBiotech: NeuroSearch convicted of stock manipulation, VBL IPO unravels, Prosensa plans EMA filing and more. Report | Follow @FierceBiotech

@DamianFierce: CF biotech ProQR, pursuing a $75M IPO, employs a "happiness manager." | Follow @DamianFierce

@EmilyMFierce: Glaxo quietly edges toward Ebola vaccine but clinical barriers remain. FierceVaccines story | Follow @EmilyMFierce

> The FDA wants more data on Acura Pharmaceuticals' ($ACUR) investigational painkiller, signaling that the company may need to run another clinical trial to demonstrate the drug's abuse deterrence. Story

> Ligand Pharmaceuticals ($LGND) has signed a deal with Avion Pharmaceuticals, lending out its Captisol platform for use in four in-development drugs. More

> Indian Prime Minister Narendra Modi is considering launching state-funded research institutions focused on biotech and pharma. Article

Medical Device News

@FierceMedDev: Researchers explore 'shape-shifting' material for facial reconstruction. More | Follow @FierceMedDev

@StacyALawrence: ICYMI: Intel, Michael J. Fox Foundation start smartwatch study to track Parkinson's patients. Story | Follow @StacyALawrence

@VarunSaxena2: RT @FierceMedicalDev: We're looking for fierce women at the top of their game in #medtech. Learn more about how to nominate. More | Follow @VarunSaxena2

@EmilyWFierce: Senate democrats outlining a proposal to crack down on corporate tax inversions. Story via The Wall Street Journal | Follow @EmilyWFierce

> Foundation Medicine teams with MD Anderson for new trial of cancer Dx. News

> Top U.S. senator urges Hospira to abandon inversion plans. Story

> FDA launches pilot program for qualification of medical device development tools. Article

> Researchers explore 'shape-shifting' material for facial reconstruction. More

Pharma News

@FiercePharma: ICYMI earlier: Skeptical U.K. watchdogs decide to back Gilead's hep C star Sovaldi. News | Follow @FiercePharma

@EricPFierce: Amgen recalls Aranesp from UK, Russia, 7 other countries after polyester particles found in syringes. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: Valeant, Pershing Square: Bring on the SEC insider trading probe. More | Follow @CarlyHFierce

> Roche's Avastin nabs quick FDA nod for cervical cancer use. News

> NICE Zytiga snub is 'plainly illogical,' critics say. Story

> Bloomberg: Roche negotiating for rest of Chugai for $10B. More

Suggested Articles

In this week's EuroBiotech Report, Sitryx inks Lilly deal, Genfit downplays COVID-19 impact on NASH data and Gilead tests remdesivir in U.K.

Amgen and new partner Adaptive Biotechnologies are the latest pharma-biotech duo joining forces against the pandemic.

In our EuroBiotech roundup this week, AM-Pharma raises €23 million, Nordic Nanovector makes cuts and Neurimmune, Ethris plan COVID-19 trial.